期刊文献+

单纯疱疹病毒Ⅰ型糖蛋白D胞外区的真核表达及生物学活性分析 被引量:6

Eucaryotic expression and bioactivity analysis of the recombinant HSV-gD1
原文传递
导出
摘要 单纯疱疹病毒(Herpes simplex virus,HSV)包膜糖蛋白D(glycoprotein D,gD)是HSV的结构蛋白之一,具有重要抗原表位,是目前疫苗研究的热点。为了分离纯化HSV gD1糖蛋白胞外区片段并对其生物学活性进行分析,本研究将化学合成的gD1胞外区基因片段克隆至真核表达载体pCEP4,重组质粒转染HEK293细胞进行瞬时表达,产物经Western blotting检测后用亲和层析法进行分离纯化,ELISA检测其抗原性。以纯化的重组蛋白作为抗原免疫小鼠,ELISA测血清特异性抗体效价以评价其免疫原性。构建的重组质粒经测序显示基因序列完全正确。表达产物的Western blotting分析发现,在相对分子量约46kDa处有外源蛋白表达,与预期蛋白带一致。用Ni柱得到了纯化的重组gD1蛋白,ELISA检测显示其具有良好的抗原性,免疫小鼠7周后血清中抗体效价达到5×103。重组gD1蛋白的抗原性及免疫原性分析为HSV检测试剂和基因重组亚单位疫苗的研制提供了实验依据。 Envelope proteins of herpes simplex virus (HSV) plays a vital role not only in the infection process of adsorption and invasion but also in the stimulation to the organism that gives rise to immune response. Among the envelope proteins, glycoprotein D (gD), which can induce specific immune response, are the primary targets of humoral and cellular immunity of the host. In order to analyze the antigenicity and immunogenicity of HSV-gD1, we chemically synthesized the extracellular domain fragment gene of gD1, cloned it into eucaryotic expression vector pCEP4, and transfected the HEK293 cells with the recombinant vector. Then we identified the recombinant protein by Western blotting, and detected antigenicity of the protein by ELISA. Finally, we used the purified gD1 protein to immunize Kunming mice in 1, 3, 5 weeks, and collected antiserum in 3, 5 and 7 weeks. We titrated the sera for the detection of anti gD1 using an ELISA assay. Gene sequencing analysis demonstrated that the recombinant plasmid pCEP4-gD1 was constructed successfully. Western blotting analysis indicated one major protein band, which molecular weights is approximate 46 kDa corresponding to the truncated forms of gD1 protein, was observed. ELISA assay showed that the expressed recombinant protein gD1 had good antigenicity. After the third immunization, antibody titer of the mouse anti-gD1 was at least 5×10^3. The successful expression of the recombinant protein gD1, which can induce humoral immune response, lays a foundation for serological diagnosis and vaccine study of HSV.
出处 《生物工程学报》 CAS CSCD 北大核心 2010年第5期657-663,共7页 Chinese Journal of Biotechnology
基金 国家高技术研究发展计划(863计划)(No.2006AA02A226)资助~~
关键词 单纯疱疹病毒 包膜糖蛋白gD1 真核表达 抗原性 免疫原性 Herpes simplex virus Type I (HSV-I) gD1 eucaryotic cell expression antigenicity immunogenicity
  • 相关文献

参考文献13

  • 1Levi M, Ruden U, Wahren B, et al. Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV2) and HSV1 antibodies. Clin Diagn Lab Immunol, 1996, 3(3): 265-269.
  • 2Whitley RJ, Kimberlin DW, Roizman B. Herpes simplex viruses. Clin lnfect Dis, 1998, 26(3): 541-555.
  • 3Straus SE, Croen KD, Sawyer MH, et al. Acyclovir suppression of frequently recurring genital herpes: efficacy and diminishing need during successive years of treatment. JAMA, 1988, 260(15): 2227-2230.
  • 4Kaplowitz LG, Baker D, Gelb L, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection.The acyclovir study group. JAMA, 1991, 265(6): 747-751.
  • 5Stanberry LR, Cunningham AL, Mindel A, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis, 2000, 30(3): 549-566.
  • 6Whitley RJ, Roizman B. Herpes simplex viruses: is a vaccine tenable? J Clin lnvest, 2002, 110(2): 145-151.
  • 7Lilie H, Schwarz E, Rudolph R. Advances in refolding of proteins produced in E. coil Curr Opin Biotechnol, 1998, 9(5): 497-501.
  • 8Andersen DC, Krummen L. Recombinant protein expression for therapeutic applications. Curr Opin Biotechnol, 2002, 13(2): 117-123.
  • 9Spear PG. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol, 2004, 6(5): 401-410.
  • 10Stanberry LR, Spruance SL, Cunningham AL, et al. Glycoprotein D adjuvant vaccine to prevent genital herpes. NEngl JMed, 2002, 347(21): 1652-1661.

同被引文献48

  • 1许丽锋,张中洋,李秀玲,何薇薇.人巨细胞病毒gB基因真核表达载体的构建与鉴定[J].中国生物制品学杂志,2004,17(5):284-286. 被引量:3
  • 2马永刚,余荭,王金忠,陈启民,耿运琪.牛泡沫病毒跨膜蛋白的穿膜区具有细胞毒性作用[J].南开大学学报(自然科学版),2005,38(2):49-53. 被引量:1
  • 3王战勇,王志玉,温红玲,陶泽新.重组抗原在HSV-Ⅰ感染ELISA检测中的应用[J].中华实验和临床病毒学杂志,2005,19(2):159-161. 被引量:3
  • 4邓宁,向军俭,唐勇,王宏,粟宽源.重组人源抗HBsAg Fab的糖基化分析[J].细胞与分子免疫学杂志,2005,21(5):658-660. 被引量:3
  • 5洪健,周雪平.ICTV第八次报告的最新病毒分类系统[J].中国病毒学,2006,21(1):84-96. 被引量:88
  • 6Liljeqvist JA, Svennerholm B, Bergstrom T. Conservation of type- specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates [J]. Clin Microbiol, 2000, 38 (12): 4517- 4522.
  • 7Liljeqvist JA, Trybala E, Svennerholm B, et al. Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies [J]. Gen Virol, 1998, 79 (5): 1215-1224.
  • 8Grabowska AC, Jameson P, Laing S, et al. Identification of type specific domains within glycoprotein G of herpes simplex virus type 2 (HSV-2) recognized by the majority of patients infected with HSV-2, hut not by those infected with HSV-1 [J]. Gen Virol, 1999, 80: 1789-1798.
  • 9Parker JN, Pfister LA, QueneUe D, et al. Genetically engineered herpes smiplex viruses that express IL-12 or GM-CSF as vaccine candidates[J]. Vaccine, 2006, 24 (10): 1644-1652.
  • 10陆健.蛋向质纯化技术及应用[M].北京:化学工业出版社,2005.12-15.

引证文献6

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部